S-CK, S-ALT, S-AST and S-LDH levels were significantly elevated in the hyperCKemia group compared to the control group, but no disease markers associated with risk of polyneuropathy such as blood sugar abnormalities or B12 deficiency in any group were detected (Table 1). This evidence concerns the gene GPT and polyneuropathy.